核医学イメージング装置の市場規模、シェア、成長分析：技術別、製品タイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

核医学イメージング装置の世界市場規模は、2023年に23億米ドルと評価され、2024年の24億7,000万米ドルから2032年には44億1,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは7.5%で成長する見通しです。

世界の核医学イメージング装置市場は、医療画像技術の進歩と慢性疾患の有病率の上昇に後押しされ、力強い成長を遂げています。特に加齢に関連した疾患に罹患しやすい高齢化社会は、腫瘍学、心臓病学、神経学におけるアプリケーションの増加とともに、この市場を推進しています。PETやSPECTとCTを統合したハイブリッド画像診断システムの急増は、包括的な解剖学的・機能的洞察を提供することで診断能力を高めています。さらに、AIと機械学習の統合により、これらの装置の効率と精度が向上しています。しかし、高コストや特定の地域での償還制限などの課題が、拡大の妨げになる可能性があります。このような状況にもかかわらず、ヘルスケアインフラが進化し、最終的に患者の転帰を向上させるにつれて、イノベーションと戦略的パートナーシップには大きな機会が存在します。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術の進歩

核医学イメージング装置市場規模：技術別& CAGR（2025-2032）

• 市場概要
• 単一光子放出コンピュータ断層撮影（SPECT）
• 陽電子放出断層撮影（PET）

核医学イメージング装置市場規模：製品タイプ別& CAGR（2025-2032）

• 市場概要
• PETデバイス
  • スタンドアロンPET
  • PET/CT
  • PET/MRI
• SPECT装置
  • スタンドアロンSPECT
  • スペクトラムCT
  • SPECT/MRI
• 平面イメージングデバイス

核医学イメージング装置市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 腫瘍学
• 心臓病学
• 神経学
• その他

核医学イメージング装置市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 画像センター
• 学術研究センター
• その他

核医学イメージング装置市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• GE HealthCare Technologies（United States）
• Siemens Healthineers（Germany）
• Philips Healthcare（Netherlands）
• Canon Medical Systems Corporation（Japan）
• Neusoft Medical Systems Co., Ltd.（China）
• Mediso Ltd.（Hungary）
• Digirad Corporation（United States）
• CMR Naviscan Corporation（United States）
• Shimadzu Corporation（Japan）
• PerkinElmer（United States）
• MILabs B.V.（Netherlands）
• MR Solutions Ltd.（United Kingdom）
• SurgicEye GmbH（Germany）
• Triad Isotopes（United States）
• Cardinal Health（United States）
• Lantheus Holdings（United States）
• Medtronic（United States）
• Bayer（Germany）
• SHINE Technologies（United States）

結論と推奨事項

Global Nuclear Imaging Devices Market size was valued at USD 2.3 billion in 2023 and is poised to grow from USD 2.47 billion in 2024 to USD 4.41 billion by 2032, growing at a CAGR of 7.5% during the forecast period (2025-2032).

The global nuclear imaging devices market is experiencing robust growth, fueled by advancements in medical imaging technology and a rising prevalence of chronic diseases. The aging population, especially susceptible to age-related conditions, along with increasing applications in oncology, cardiology, and neurology, propels this market forward. The surge in hybrid imaging systems, which integrate PET or SPECT with CT, enhances diagnostic capabilities by providing comprehensive anatomical and functional insights. Additionally, the integration of AI and machine learning is improving the efficiency and accuracy of these devices. However, challenges such as high costs and limited reimbursement in certain regions could hinder expansion. Despite this, substantial opportunities exist for innovation and strategic partnerships as healthcare infrastructures evolve, ultimately enhancing patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nuclear Imaging Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nuclear Imaging Devices Market Segmental Analysis

Global Nuclear Imaging Devices Market is segmented by Technology, Product Type, Application, End User and region. Based on Technology, the market is segmented into Single-Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET). Based on Product Type, the market is segmented into PET Devices, SPECT Devices and Planar Imaging Devices. Based on Application, the market is segmented into Oncology, Cardiology, Neurology and Others. Based on End User, the market is segmented into Hospitals, Imaging Centers, Academic and Research Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nuclear Imaging Devices Market

The global nuclear imaging devices market is significantly driven by rapid technological advancements, including the emergence of hybrid imaging systems and molecular imaging methods that greatly improve diagnostic accuracy and efficiency. These innovations empower healthcare professionals to gain deeper insights into the functioning of organs and tissues, thereby enhancing patient outcomes. Moreover, the incorporation of artificial intelligence (AI) and machine learning algorithms into these imaging devices is further elevating image quality and diagnostic capabilities, enabling medical practitioners to make more informed decisions. As a result, these cutting-edge developments are playing a crucial role in steering the growth of the nuclear imaging devices market worldwide.

Restraints in the Global Nuclear Imaging Devices Market

The global nuclear imaging devices market faces significant restraints primarily due to the high costs associated with these technologies. The initial capital investment for purchasing and installing nuclear imaging devices, along with ongoing maintenance expenses, can be substantial. This financial burden particularly affects developing regions where healthcare budgets are constrained. Moreover, the expenses related to radioactive isotopes utilized in imaging procedures further escalate overall costs. As a result, the high pricing acts as a deterrent for market entry and can hinder the widespread adoption of these devices, especially among healthcare facilities facing financial limitations. Addressing these cost-related issues is crucial for promoting market growth.

Market Trends of the Global Nuclear Imaging Devices Market

The Global Nuclear Imaging Devices market is witnessing a notable trend towards the growing demand for hybrid imaging systems, which merge modalities like positron emission tomography (PET) or single-photon emission computed tomography (SPECT) with computed tomography (CT) or magnetic resonance imaging (MRI). This integration delivers comprehensive anatomical and functional insights in one scan, enhancing disease characterization and treatment planning. Healthcare professionals benefit from the ability to accurately pinpoint abnormalities, assess their metabolic activity, and evaluate their effects on adjacent tissues. This trend is fueled by a push for improved diagnostic accuracy and personalized medicine, positioning hybrid systems as critical tools in modern healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Nuclear Imaging Devices Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Single-Photon Emission Computed Tomography (SPECT)
• Positron Emission Tomography (PET)

Global Nuclear Imaging Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• PET Devices
  • Standalone PET
  • PET/CT
  • PET/MRI
• SPECT Devices
  • Standalone SPECT
  • SPECT/CT
  • SPECT/MRI
• Planar Imaging Devices

Global Nuclear Imaging Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Oncology
• Cardiology
• Neurology
• Others

Global Nuclear Imaging Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Imaging Centers
• Academic and Research Centers
• Others

Global Nuclear Imaging Devices Market Size & CAGR (2025-2032)

• North America (Technology, Product Type, Application, End User)
  • US
  • Canada
• Europe (Technology, Product Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• GE HealthCare Technologies (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neusoft Medical Systems Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediso Ltd. (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Digirad Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CMR Naviscan Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MILabs B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MR Solutions Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SurgicEye GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Triad Isotopes (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lantheus Holdings (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SHINE Technologies (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations